Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss Due to Radiation Retinopathy

NCT05844982 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.

NCT NCT05844982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05844982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss Due to Radiation Retinopathy
Lead sponsor
Jaeb Center for Health Research
Phase
Phase 3
Overall status
Recruiting
Start date
November 21, 2023
Completion date
December 26, 2029
Enrollment
600 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

radiation retinopathy, visual impairment